Medizinische Universität Graz - Research portal
Selected Publication:
SHR Neuro Cancer Cardio Lipid Metab Microb
Stanzel, S; Weitzer, F; Janek, E; Plhak, E; Aigner, RM.
Atypical Presentation of Liver Metastases of Prostate Cancer in 68Ga-PSMA-11 PET/CT.
Clin Nucl Med. 2023; 48(12): 1064-1065.
Doi: 10.1097/RLU.0000000000004898
(- Case Report)
Web of Science
PubMed
FullText
FullText_MUG
- Leading authors Med Uni Graz
- Stanzel Susanne
- Co-authors Med Uni Graz
- Aigner Reingard
- Janek Elmar
- Plhak Elisabeth
- Weitzer Friedrich
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- 68Ga-PSMA-11 (68Ga-prostate-specific membrane antigen-11) PET/CT continues to have a great clinical value for staging in prostate cancer. Lymph nodes and bone are the most typical metastatic sites of prostate cancer, whereas liver metastases are rare and usually show focally increased tracer uptake in 68Ga-PSMA-11 PET/CT. Here, we present an 88-year-old man with histologically proven metastatic castration-resistant prostate cancer and extensive PSMA-negative liver metastases identified by 68Ga-PSMA-11 PET/CT. This finding is remarkable because the decreased liver uptake of 68Ga-PSMA-11 may resemble a primary hepatic tumor.
- Find related publications in this database (Keywords)
- Ga-68-PSMA-11 PET/CT
- metastatic castration-resistant prostate cancer
- PSMA-negative liver metastases